GlassScriptPhysician profile
Wilbur Ji
NPI 1588292452
$903.18
in general payments reported to CMS, 2019-2025
10 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $89.15 · 2022: $187 · 2023: $305 · 2024: $95.30 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $210.85 | 2021-2023 | Epclusa |
| Davol INC. | $149.81 | 2022 | |
| Chiesi USA, INC. | $132.04 | 2022-2025 | Kengreal, Cleviprex |
| Pfizer INC. | $123.55 | 2023 | |
| Bridgebio Pharma, INC. | $115.49 | 2025 | Attruby |
| Medtronic, INC. | $68.21 | 2023-2025 | Azure Xt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $43.15 | 2024 | |
| Shockwave Medical, INC | $22.71 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $19.67 | 2023 | Verquvo |
| Lantheus Medical Imaging, INC. | $17.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilbur Ji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.